David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 304



81
TITLE: Second-line lenvatinib in patients with recurrent endometrial cancer  Full Text
AUTHORS: Ignace Vergote; Matthew A Powell; Michael G Teneriello; David Scott Miller ; Agustin A Garcia; Olga N Mikheeva; Mariusz Bidzinski; Cristina Ligia Cebotaru; Corina E Dutcus; Min Ren; Tadashi Kadowaki; Yasuhiro Funahashi; Richard T Penson;
PUBLISHED: 2020, SOURCE: Gynecologic Oncology, VOLUME: 156, ISSUE: 3
INDEXED IN: Scopus CrossRef: 57
IN MY: ORCID | CIÊNCIAVITAE
82
TITLE: A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer.
AUTHORS: Vicky Makker; Antonio Casado Herraez; Carol Aghajanian; Keiichi Fujiwara; Sandro Pignata; Richard T Penson; Corina E Dutcus; Matthew Guo; Lea Dutta; Robert Orlowski; Alan Smith; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 15_suppl
INDEXED IN: CrossRef: 9
IN MY: ORCID | CIÊNCIAVITAE
83
TITLE: A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee Leigh Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu Sujata Tewari; Larry J Copeland; Angeles Alvarez Secord; David G Mutch; Alessandro Santin; William Richards; David Philip Warshal; Nicola M Spirtos; Paul Disilverstro; Olga Ioffe; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 15_suppl
INDEXED IN: CrossRef: 28
IN MY: ORCID | CIÊNCIAVITAE
84
TITLE: Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer
AUTHORS: Daniela Matei; Virginia Filiaci; Marcus E Randall; David Mutch; Margaret M Steinhoff; Paul A DiSilvestro; Katherine M Moxley; Yong M Kim; Matthew A Powell; David M O’Malley; Nick M Spirtos; William Small; Krishnansu S Tewari; William E Richards; John Nakayama; Ursula A Matulonis; Helen Q Huang; David Scott Miller ;
PUBLISHED: 2019, SOURCE: New England Journal of Medicine, VOLUME: 380, ISSUE: 24
INDEXED IN: Scopus CrossRef: 329
IN MY: ORCID | CIÊNCIAVITAE
85
TITLE: Baseline platelet count and body weight as predictors of early dose modification in the quadra trial of niraparib monotherapy for the treatment of heavily pretreated (≥4th line), advanced, recurrent high-grade serous ovarian cancer  Full Text
AUTHORS: U.A Matulonis; B.J Monk; A.A Secord; M.A Geller; David Scott Miller ; N.G Cloven; G.F Fleming; A.E Wahner Hendrickson; Azodi, M; P.A DiSilvestro; A.M Oza; Cristea, M; J.S Berek; J.K Chan; Li, Y; Luptakova, K; S.J Hazard; K.N Moore;
PUBLISHED: 2019, SOURCE: Gynecologic Oncology, VOLUME: 154
INDEXED IN: CrossRef: 6
IN MY: ORCID | CIÊNCIAVITAE
86
TITLE: Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?. Should We Screen for Lynch Syndrome in Precancerous Lesions?
AUTHORS: Elena Lucas; Hao Chen; Kyle Molberg; Diego H Castrillon; Glorimar Rivera Colon; Long Li; Stacy Hinson; Joel Thibodeaux; Jayanthi Lea; David Scott Miller ; Wenxin Zheng;
PUBLISHED: 2019, SOURCE: International Journal of Gynecological Pathology, VOLUME: 38, ISSUE: 6
INDEXED IN: Scopus CrossRef: 28
IN MY: ORCID | CIÊNCIAVITAE
87
TITLE: Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
AUTHORS: Kathleen N Moore; Angeles Alvarez Secord; Melissa A Geller; David Scott Miller ; Noelle Cloven; Gini F Fleming; Andrea E Wahner Hendrickson; Masoud Azodi; Paul DiSilvestro; Amit M Oza; Mihaela Cristea; Jonathan S Berek; John K Chan; Bobbie J Rimel; Daniela E Matei; Yong Li; Kaiming Sun; Katarina Luptakova; Ursula A Matulonis; Bradley J Monk;
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 5
INDEXED IN: Scopus CrossRef: 379
IN MY: ORCID | CIÊNCIAVITAE
88
TITLE: Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/ carboplatin in high-intermediate and high-risk early stage endometrial cancer
AUTHORS: Marcus E Randall; Virginia Filiaci; Scott S McMeekin; Vivian Von Gruenigen; Helen Huang; Catheryn M Yashar; Robert S Mannel; Jae Weon Kim; Ritu Salani; Paul A DiSilvestro; James J Burke; Thomas Rutherford; Nick M Spirtos; Keith Terada; Penny R Anderson; Wendy R Brewster; William Small; Carol A Aghajanian; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 21
INDEXED IN: Scopus CrossRef: 246
IN MY: ORCID | CIÊNCIAVITAE
89
TITLE: Reply to F. Tomao et al
AUTHORS: Martee L Hensley; Danielle Enserro; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 11
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
90
TITLE: Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial.
AUTHORS: Gloria S Huang; Melissa A Merritt; Alan Hutson; Howard D Strickler; Mark Einstein; Jurriaan Brouwer-Visser; Nilsa C Ramirez; Heather A Lankes; Mona El-Bahrawy; Xiaonan Xue; Herbert Yu; Robert S Mannel; David M O'Malley; David Gardner Mutch; Paul Disilvestro; Melissa Ann Geller; Saketh R Guntupalli; Michael J Birrer; David Scott Miller ; Marc J Gunter;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 15_suppl
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 9 of 31. Total results: 304.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service